N-[[3-(cyclopropylsulfonylamino)-4,5-difluorophenyl]methyl]-5-(6-ethoxypyrazin-2-yl)-1,3-thiazole-2-carboxamide
C20H19F2N5O4S2 — CID 163271011
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[3-(cyclopropylsulfonylamino)-4,5-difluorophenyl]methyl]-5-(6-ethoxypyrazin-2-yl)-1,3-thiazole-2-carboxamide
N-[[3-(cyclopropylsulfonylamino)-4,5-difluorophenyl]methyl]-5-(6-ethoxypyrazin-2-yl)-1,3-thiazole-2-carboxamide (PubChem CID 163271011) has the molecular formula C20H19F2N5O4S2 and a molecular weight of 495.53 g/mol. Its IUPAC name is N-[[3-(cyclopropylsulfonylamino)-4,5-difluorophenyl]methyl]-5-(6-ethoxypyrazin-2-yl)-1,3-thiazole-2-carboxamide.
Molecular Properties
| Compound Name | N-[[3-(cyclopropylsulfonylamino)-4,5-difluorophenyl]methyl]-5-(6-ethoxypyrazin-2-yl)-1,3-thiazole-2-carboxamide |
|---|---|
| PubChem CID | 163271011 |
| Molecular Formula | C20H19F2N5O4S2 |
| Molecular Weight | 495.53 g/mol |
| Exact Mass | 495.08 |
| IUPAC Name | N-[[3-(cyclopropylsulfonylamino)-4,5-difluorophenyl]methyl]-5-(6-ethoxypyrazin-2-yl)-1,3-thiazole-2-carboxamide |
| SMILES | CCOc1cncc(-c2cnc(C(=O)NCc3cc(F)c(F)c(NS(=O)(=O)C4CC4)c3)s2)n1 |
| InChI | InChI=1S/C20H19F2N5O4S2/c1-2-31-17-10-23-8-15(26-17)16-9-25-20(32-16)19(28)24-7-11-5-13(21)18(22)14(6-11)27-33(29,30)12-3-4-12/h5-6,8-10,12,27H,2-4,7H2,1H3,(H,24,28) |
| InChIKey | UEPRNJFTHKJCHE-UHFFFAOYSA-N |
| XLogP | 3.11 |
| TPSA | 123.17 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 495.53 |
| LogP ≤ 5 | 3.11 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163271011 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.